VanEck Pharmaceutical ETF
Shareclass
VanEck Pharmaceutical ETF (PPH)
Type
Exchange-traded fund
Manager
Gender equality score
63
/ 100 points
Overall score
Average Equileap Gender Equality Score of fund holdings, weighted by market value
Group ranking
All funds
Groups
Categories
Gender balance in leadership and workforce
32/40
Equal compensation and work life balance
12/30
Policies promoting gender equality
19/20
Commitment, transparency, and accountability
1/10

Sustainability report card
As You Sow’s Invest Your Values report card grades mutual funds on environmental and social issues, including climate change, gender equality, and weapon investments. Click through to get more details on each issue.
VanEck Pharmaceutical ETF PPH
Environment
Social
Search more funds
Top scoring holdings
The top 10 holdings in this portfolio with the best scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.
- 1. Sanofi SA ADR4.81% of assets$30.66M invested
- 2. AstraZeneca PLC ADR4.9% of assets$31.25M invested
- 3. GSK PLC ADR4.66% of assets$29.7M invested
- 4. Haleon PLC ADR4.69% of assets$29.9M invested
- 5. Takeda Pharmaceutical Co Ltd ADR4.76% of assets$30.33M invested
- 6. Novartis AG ADR5.4% of assets$34.39M invested
- 7. Novo Nordisk AS ADR4.5% of assets$28.69M invested
- 8. Johnson & Johnson6.45% of assets$41.09M invested
- 9. Bristol-Myers Squibb Co3.83% of assets$24.39M invested
- 10. Merck & Co Inc4.69% of assets$29.88M invested
Bottom scoring holdings
The bottom 10 holdings in this portfolio with the worst scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.
- 1. Bausch Health Companies Inc0.4% of assets$2.53M invested
- 2. Axsome Therapeutics Inc1.07% of assets$6.81M invested
- 3. Viatris Inc2.28% of assets$14.52M invested
- 4. Perrigo Co PLC0.85% of assets$5.39M invested
- 5. McKesson Corp5.13% of assets$32.72M invested
- 6. Elanco Animal Health Inc0.99% of assets$6.32M invested
- 7. Eli Lilly and Co13% of assets$83.52M invested
- 8. Jazz Pharmaceuticals PLC1.85% of assets$11.78M invested
- 9. Pfizer Inc4.3% of assets$27.42M invested
- 10. Teva Pharmaceutical Industries Ltd ADR4.4% of assets$28.02M invested
Find sustainably-invested mutual funds and ETFs
Search for funds from your 401(k), retirement plan, or personal portfolio
Financial performance
Performance data provided by
Find more financial data on PPH at Morningstar.com

Gender Equality and Returns

Enlarge
The figure above charts annualized returns and Gender Equality Fund grades. The orange marker represents this fund. The purple marker (if present) represents an assigned benchmark. Blue dots represent funds in the same Morningstar category as this fund. Dark gray dots represent funds in the same grading group as this fund. Returns are for the most recent available for this fund of 1, 3, 5, or 10 year annualized returns. The higher a fund is marked on the Y axis, the better its returns for the specified time period. The higher a fund is marked on the X axis, the better its Gender Equality Funds group ranking. Read more on the How it Works page.
Benchmarking tool
Ask your employer about gender-lens investing in your retirement plan
Find socially responsible funds that invest in gender equality
Learn more about As You Sow's Invest Your Values program
Visit Fossil Free Funds to measure the climate risk of this portfolio
More from Invest Your Values
See how mutual funds and ETFs are rated on issues ranging from fossil fuels, to deforestation, gender equality, guns, prisons, weapons, and tobacco
Disclaimer: As You Sow is not an investment adviser
As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer
See our full disclaimer